[Role of clustered amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer].
暂无分享，去创建一个
L. Zavalishina | Y. Andreeva | I. Poddubnaya | N. Savelov | I. V. Kolyadina | A. Meshcheryakov | O. Gordeeva | L. G. Zhukova | G. Frank | I. Ganshina | D. A. Morozov | E. Tuzova